1-5 of 5
Michael von Bergwelt-Baildon
Close
Save search
Sort by
Journal Articles

Gastrointestinal toxicity of Gemtuzumab Ozogamicin: Real-life data from the AMLCG, SAL and CELL study groups

Open Access
Clinical Trials & Observations
Ricarda Knabe, Philippe Muller, Christoph Schliemann, Maher Hanoun, Julia Marie Unglaub, Barbora Weinbergerová, Jiri Mayer, Carolin Krekeler, Stefan W Krause, Martin Kaufmann, Sabrina Kraus, Björn Steffen, Franziska Modemann, Marion Subklewe, Veit L. Bücklein, Wolfgang G. Kunz, Martina Rudelius, Michael von Bergwelt-Baildon, Katja Gutmair, Eva Hoster, Tobias Herold, Christoph Röllig, Karsten Spiekermann
Journal: Blood Advances
Blood Adv bloodadvances.2024014570.
https://doi.org/10.1182/bloodadvances.2024014570
Published: 2025
Includes: Supplemental data
Journal Articles

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Free
Viktoria Blumenberg, Galina Busch, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Laura Gallur, Josu Iraola-Truchuelo, Eva Hoster, Michael Winkelmann, Konstantin Hellwig, Christian Schmidt, Lisa Frölich, Benjamin Tast, Friederike Hildebrand, Kai Rejeski, Franziska Dekorsy, Christian Schmidkonz, Tobias Bäuerle, Wolfgang G. Kunz, Dimitrios Mougiakakos, Fabian Müller, Michael von Bergwelt-Baildon, Pere Barba, Veit L. Bücklein, Andreas Mackensen, Simon Völkl, Marion Subklewe
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6844–6849.
https://doi.org/10.1182/bloodadvances.2023010364
Published: 2023
Includes: Supplemental data
Journal Articles

sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study

Free
Clinical Trials & Observations
Thomas Wimmer, Raphael Mattes, Hans-Joachim Stemmler, Fabian Hauck, Hendrik Schulze-Koops, Stephanie-Susanne Stecher, Michael Starck, Clemens-Martin Wendtner, Peter Bojko, Marcus Hentrich, Katharina E. Nickel, Katharina S. Götze, Florian Bassermann, Michael von Bergwelt-Baildon, Karsten Spiekermann
Journal: Blood Advances
Blood Adv (2023) 7 (5): 832–844.
https://doi.org/10.1182/bloodadvances.2022007953
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Free
Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4719–4725.
https://doi.org/10.1182/bloodadvances.2022007776
Published: 2022
Includes: Supplemental data
Journal Articles

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment

Free
Clinical Trials & Observations
Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3022–3026.
https://doi.org/10.1182/bloodadvances.2021006144
Published: 2022